Intravenously Administered Nonsteroidal Anti-Inflammatory Drugs in Clinical Practice: A Narrative Review
Pharmacy · 04.02.2025 · 13 (1) · 18
DOI: 10.3390/pharmacy13010018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacy, online erschienen am 04.02.2025. Verfasst von Axel Maurice-Szamburski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Critical Care, Pasteur University Hospital, 06300 Nice, France. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: B. Braun (France), B.Braun Medical SAS.
Abstract (Originalsprache)
Intravenously administered nonsteroidal anti-inflammatory drugs (NSAIDs) constitute a crucial component of multimodal analgesia strategies in surgical settings. This narrative review aims to provide an up-to-date evaluation of the efficacy, safety, and clinical use of intravenous (IV) NSAIDs for perioperative pain management in adults and children. The NSAIDs and selective COX-2 inhibitors (coxibs) approved in Europe for the short-term symptomatic treatment of acute, moderate perioperative pain via IV infusion in adults and/or children have been influenced by US and global guidelines and practice: the drugs primarily reviewed here are ibuprofen, ketorolac, ketoprofen, naproxen, paracetamol, and acetylsalicylic acid. Furthermore, intravenous ibuprofen is authorized for the short-term symptomatic treatment of fever. In contrast to intravenous ketoprofen, intravenous ibuprofen is authorized for administration to children over 6 years of age or weighing more than 20 kg. Overall, IV ibuprofen had a more favorable profile with regard to peri- and postoperative opioid sparing and pain relief. Oral ibuprofen and IV ibuprofen have similar levels of efficacy, although IV ibuprofen has a shorter onset of action and is required in patients who are unable to take oral medications. The frequency of significant adverse events appears to be similar for ibuprofen and paracetamol. Systematic reviews and meta-analyses report that intravenous NSAIDs reduce postoperative opioid consumption by approximately 20–60%, improving pain management with fewer opioid-related side effects. In indications in infants, the choice of medication is limited, and the oral route is not always feasible; IV formulations of ibuprofen are preferred in this setting. Topics for further research should include head-to-head trials of IV NSAIDs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology and Critical Care, Pasteur University Hospital, 06300 Nice, France.
- Clinique Drouot Sport, 75009 Paris, France.
- Anesthesia and Intensive Care Department, Raymond Poincaré Hospital, APHP, 92380 Garches, France.
- Department of Anesthesiology and Critical Care, L'Archet University Hospital, 06200 Nice, France.
- Department of Anesthesiology, Intensive Care and Perioperative Medicine, Clinical Epidemiology, Public Health, and Innovation in Methodology, CHU Nimes, University Montpellier, 30908 Nimes, France.
- Department d'Anesthésie Réanimation and Médecine Péri Opératoire, Hôpital Pontchaillou, Université Rennes, 35000 Rennes, France.
ORCID-Profile: Axel Maurice-Szamburski, Cyril Quemeneur, Romain Rozier, Claude Ecoffey
Förderung
- B. Braun (France)
- B.Braun Medical SAS
Zitieren
APA
Maurice-Szamburski, A., Quemeneur, C., Rozier, R., Cuvillon, P., & Ecoffey, C. (2025). Intravenously Administered Nonsteroidal Anti-Inflammatory Drugs in Clinical Practice: A Narrative Review. Pharmacy, 13(1), 18. https://doi.org/10.3390/pharmacy13010018
Vancouver
Maurice-Szamburski A, Quemeneur C, Rozier R, Cuvillon P, Ecoffey C. Intravenously Administered Nonsteroidal Anti-Inflammatory Drugs in Clinical Practice: A Narrative Review. Pharmacy. 2025;13(1):18. doi:10.3390/pharmacy13010018
BibTeX
@article{MauriceSzamburski2025,
author = {Maurice-Szamburski, Axel and Quemeneur, Cyril and Rozier, Romain and Cuvillon, Philippe and Ecoffey, Claude},
title = {Intravenously Administered Nonsteroidal Anti-Inflammatory Drugs in Clinical Practice: A Narrative Review},
journal = {Pharmacy},
year = {2025},
volume = {13},
number = {1},
pages = {18},
doi = {10.3390/pharmacy13010018}
}
EUVIMED